Tuberculosis Rifampicin-resistant

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-06-26
Clinical Trial Update: The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB) [Phase 4]
Phase 4 clinical trial assessing the safety and efficacy of a bedaquiline-delamanid-linezolid regimen in pulmonary MDR-TB and rifampicin-res…